Literature DB >> 26982793

Syndrome in question.

Monique Coelho Dalapicola1, John Verrinder Veasey1, Rute Facchini Lellis1.   

Abstract

Ross syndrome is a rare disease characterized by peripheral nervous system dysautonomia with selective degeneration of cholinergic fibers. It is composed by the triad of unilateral or bilateral segmental anhidrosis, deep hyporeflexia and Holmes-Adie's tonic pupil. The presence of compensatory sweating is frequent, usually the symptom that most afflicts patients. The aspects of the syndrome are put to discussion due to the case of a male patient, caucasian, 47 years old, with clinical onset of 25 years.

Entities:  

Mesh:

Year:  2016        PMID: 26982793      PMCID: PMC4782661          DOI: 10.1590/abd1806-4841.20163918

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


CASE REPORT

White, 47-year-old male patient with prior systemic hypertension, had been taking captopril as daily medication. He was referred by the Neurology department because he had presented a clinical picture of anhidrosis over the right hemiface and hemithorax for 25 years, associated with diminished visual acuity in the left eye. Ten years ago it progressed with extension of the area with anhidrosis to the left hemibody and onset of hyperchromatic macule, intense hyperhidrosis involving the lower abdomen, lumbar region, flanks and right lower limb (Figure 1). The Minor's test was carried out to show profuse sudoresis contrasting with the anhidrotic areas (presence of blue color on places where there is sudoresis - Figure 2). Examination of the pupil revealed anisocoria, with the left pupil larger than the right one. At the physical examination no sensitive or motor neurological alterations were observed. The histopathologic test did not demonstrate significant difference in the quantity of sweat glands between the anhidrotic and hyperhidrotic areas, or in the population of melanocytes and melanosomes, revealing absence of pigment leakage.
Figure 1

Hyperchromatic macule with intense hyperhidrosis affecting the lower abdomen, lumbar region and flanks

Figure 2

Minor’s test: bluish staining show locations where there is sudoresis

Hyperchromatic macule with intense hyperhidrosis affecting the lower abdomen, lumbar region and flanks Minor’s test: bluish staining show locations where there is sudoresis

DISCUSSION

Ross Syndrome is a rare disease of unknown cause, first described by Ross in 1958, which represents dysautonomia of the peripheral nervous system with selective degeneration of cholinergic fibers.[1,2] It is characterized by the triad of unilateral or bilateral segmental anhidrosis, deep hyporeflexia and Holmes-Adie's tonic pupil, which is distinguished by a mydriatic pupil, unresponsive to light or accommodation.[1,3,4,5] In cases where there is extensive anhidrosis, the remaining eutrophic areas with functioning eccrine sweat glands may present compensatory hyperhidrosis, the symptom that most distresses the patients, who also become uncomfortable with heat intolerance.[4,5,6] The hyperchromia observed seems to be pigmentation similar to notalgia paresthetica, in face of the histologic findings. There are other partial dysautonomias, represented by a spectrum of diseases with some common clinical characteristics, such as the Holmes-Adie syndrome, defined by tonic pupil, hyporeflexia or areflexia, Harlequin syndrome, characterized by hypohidrosis and facial flushing in response to heat, exertion or emotional factors, and Horner's syndrome by anhidrosis, ptosis, miosis and enophthalmus.[1,4,7] The diagnosis of Ross syndrome is made based on clinical symptoms, neurological signs and supplementary investigation.[8] The course of this syndrome progresses slowly, but it is benign. The complete triad usually takes years to appear.[1] This would explain, in the reported case, the presence of only two of the three alterations characteristic of the syndrome, with possible onset of deep hyporeflexia along the years. Although the thermoregulation mechanism is intensely compromised, limiting the scope of social activities of the patients, such condition does not represent risk of death, as long as the patients are oriented to develop strategies to avoid the elevation of body temperature.[8]
  10 in total

1.  Selective autonomic failure: Ross syndrome.

Authors:  Vaughan G Macefield
Journal:  Clin Neurophysiol       Date:  2012-01-20       Impact factor: 3.708

2.  Ross syndrome: a rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects.

Authors:  Maria Nolano; Vincenzo Provitera; Anna Perretti; Annamaria Stancanelli; Anna Maria Saltalamacchia; Vincenzo Donadio; Fiore Manganelli; Bernardo Lanzillo; Lucio Santoro
Journal:  Brain       Date:  2006-07-12       Impact factor: 13.501

3.  Use of topical glycopyrrolate in Ross syndrome.

Authors:  Vrinda Bajaj; Muzlifah Haniffa; Nick J Reynolds
Journal:  J Am Acad Dermatol       Date:  2006-11       Impact factor: 11.527

4.  Anhidrosis as the first sign of Ross syndrome.

Authors:  Marcus H S B Xavier; Fábio H G Porto; Gabrilela B Pereira; Luiz Peres Quevedo; Paula M de Freitas; Osvaldo J M do Nascimento; Marcos R G de Freitas
Journal:  Arq Neuropsiquiatr       Date:  2009-06       Impact factor: 1.420

5.  Ross syndrome.

Authors:  Arun Kumar Metta; S B Athanikar; S Ramachandra; Shibu Mohammad
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 Jul-Aug       Impact factor: 2.545

6.  Muscle and skin sympathetic activities in Ross syndrome.

Authors:  V Donadio; P Cortelli; M P Giannoccaro; M Nolano; V Di Stasi; A Baruzzi; R Liguori
Journal:  Clin Neurophysiol       Date:  2012-01-11       Impact factor: 3.708

7.  Ross syndrome: Unilateral hyperhidrosis, Adie's tonic pupils and diffuse areflexia.

Authors:  Sirin Yaşar; Canan Aslan; Zehra Aşiran Serdar; Gülşen Tükenmez Demirci; Kemal Tutkavul; Dilek Babalik
Journal:  J Dtsch Dermatol Ges       Date:  2010-12       Impact factor: 5.584

8.  Ross syndrome, an entity included within the spectrum of partial disautonomic syndromes.

Authors:  M Ballestero-Díez; I García-Río; E Daudén; Mj Corrales-Arroyo; A García-Díez
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-11       Impact factor: 6.166

9.  [Ross syndrome in a 38-year-old male].

Authors:  Pilar Pérez-García; Josefa Bernat-García; Almudena Mateu-Puchades
Journal:  Dermatol Online J       Date:  2013-01-15

Review 10.  Harlequin syndrome in childhood--case report.

Authors:  Juliano de Avelar Breunig; Mariana Hartmann; Cristiano Firpo Freire; Hiram Larangeira de Almeida
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.